Acquisitions17 Feb 2026, 03:26 pm
Strides Pharma Science Subsidiary Completes Acquisition of Neviton Softech
AI Summary
Arco Lab Private Limited, a wholly owned subsidiary of Strides Pharma Science Ltd, has completed the acquisition of Neviton Softech Private Limited. Neviton is engaged in providing IT services and engineering solutions, with expertise in developing machine interfaces through IoT devices and integrating live data feeds into real-time applications. Arco Lab had previously acquired a 25% equity stake in Neviton in August 2022, followed by an additional 25% stake in January 2024. The remaining 50% equity interest has now been acquired, making Neviton a wholly owned subsidiary of Arco Lab.
Key Highlights
- Arco Lab, a subsidiary of Strides Pharma Science Ltd, has completed the acquisition of Neviton Softech Private Limited.
- Neviton is engaged in providing IT services and engineering solutions, with expertise in developing machine interfaces through IoT devices and integrating live data feeds into real-time applications.
- Arco Lab had previously acquired a 25% equity stake in Neviton in August 2022, followed by an additional 25% stake in January 2024.
- The remaining 50% equity interest has been acquired, making Neviton a wholly owned subsidiary of Arco Lab.
- The acquisition is complementary to Arco Lab’s business objectives.